APA (7th ed.) Citation

H, N., G, A., F, T., & E, S. (2021). Risk and Benefit of Antiplatelet Therapy in COVID-19 Patients with Cancer and Thrombocytopenia: Letter to the Editor. Cancer investigation, 39(3), 217. https://doi.org/10.1080/07357907.2020.1871485

Chicago Style (17th ed.) Citation

H, Nourmohammadi, Azami G, Taghinezhad F, and Shafiei E. "Risk and Benefit of Antiplatelet Therapy in COVID-19 Patients with Cancer and Thrombocytopenia: Letter to the Editor." Cancer Investigation 39, no. 3 (2021): 217. https://doi.org/10.1080/07357907.2020.1871485.

MLA (9th ed.) Citation

H, Nourmohammadi, et al. "Risk and Benefit of Antiplatelet Therapy in COVID-19 Patients with Cancer and Thrombocytopenia: Letter to the Editor." Cancer Investigation, vol. 39, no. 3, 2021, p. 217, https://doi.org/10.1080/07357907.2020.1871485.